Acurx Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $14,577,768.
Profit Margin
| 2019 | 0 | -5.93M | |
|---|---|---|---|
| 2020 | 0 | -4.60M | |
| 2021 | 0 | -12.68M | |
| 2022 | 0 | -12.09M | |
| 2023 | 0 | -14.57M |
ACXP Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 6.04M | 4.75M | 2.03M | 2.20M | 3.51M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 14.57M | 12.09M | 12.81M | 4.60M | 5.93M |
Operating income | -14.57M | -12.09M | -12.88M | -4.60M | -5.93M |
Other income (expenses), net | 0 | 1.22K | 133.00K | 0 | -3 |
Income before tax | -14.57M | -12.09M | -12.74M | -4.60M | -5.93M |
Income tax expense | 0 | -1.22K | -66.50K | -4.59K | -5.93K |
Net income | -14.57M | -12.09M | -12.68M | -4.60M | -5.93M |
Earnings per share | |||||
Basic EPS | -1.15 | -1.12 | -1.24 | -0.46 | -0.6 |
Diluted EPS | -1.15 | -1.12 | -1.24 | -0.46 | -0.6 |
| Data source | Data source | Data source |